
Efamax is an HIV/ARV tablet product containing Efavirenz, an antiretroviral medicine. Efavirenz belongs to the class of medicines known as non-nucleoside reverse transcriptase inhibitors (NNRTIs).
Efavirenz works by inhibiting HIV reverse transcriptase, an enzyme that the virus requires to reproduce. By interfering with this process, Efavirenz helps reduce HIV replication when used as part of an appropriate antiretroviral treatment regimen.
Efamax HIV/ARV Tablets are available in the following strengths:
– Efamax Efavirenz 200mg
– Efamax Efavirenz 600mg
The appropriate strength and dosing schedule depend on the prescribed treatment regimen, patient-specific considerations, and the recommendations of a qualified healthcare professional.
18 total views, 2 today